Adverse events14

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 14 of 14

Type	Event	Organ system	Group	Affected	At risk
other	Dry mouth	Gastrointestinal disorders	Pregabalin	6	111
other	Dry mouth	Gastrointestinal disorders	Placebo	3	109
other	Oedema peripheral	General disorders	Pregabalin	7	111
other	Oedema peripheral	General disorders	Placebo	2	109
other	Nasopharyngitis	Infections and infestations	Pregabalin	5	111
other	Nasopharyngitis	Infections and infestations	Placebo	9	109
other	Dizziness	Nervous system disorders	Pregabalin	27	111
other	Dizziness	Nervous system disorders	Placebo	4	109
other	Somnolence	Nervous system disorders	Pregabalin	6	111
other	Somnolence	Nervous system disorders	Placebo	5	109
serious	Respiratory tract infection	Infections and infestations	Pregabalin	1	111
serious	Respiratory tract infection	Infections and infestations	Placebo	0	109
serious	Cerebral ischaemia	Nervous system disorders	Pregabalin	1	111
serious	Cerebral ischaemia	Nervous system disorders	Placebo	0	109

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01455428/events